We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity. Please visit our webpage to know more about our products and offerings https://iktos.ai/products/
Iktos Address
Paris, null France
Iktos Email
Past Companies
IktosVice President, Head of US Operations, Sales & Business Development
Nanome Inc.Vice President of Biopharma
Revenew InternationalDirector of Business Development